Formic Acid

Formic Acid

SCHEMBL18399043

O.O=C[O-].[Na+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Formic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL16649257 1.00
Formic Acid SCHEMBL8317739 1.00
Formic Acid SCHEMBL1332326 0.94
Formic Acid SCHEMBL30564965 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL5235342 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL1332681 0.94
Formic Acid SCHEMBL2354 0.94
Formic Acid SCHEMBL6906941 0.94
Formic Acid SCHEMBL23881608 0.88 ALDH1A1 (0.30)
Formic Acid SCHEMBL502309 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116041723-A Preparation method of aluminum-based metal organic framework material 佛山科学技术学院 2023-05-02 CN claimed
CN-115838321-A Electrodialysis membrane separation method for desalting green color in trimethylolpropane 南通百川新材料有限公司 2023-03-24 CN claimed
CN-109574797-B Preparation method of chiral benzyl alcohol 上海彩迩文生化科技有限公司 2021-09-17 CN claimed
CN-1795964-A Heat Recovery System for Renewable Absorbent Materials YAGAOSI ADVANCED TECH CO LTD (HK) 2006-07-05 CN claimed
CN-122014998-A Flow adaptive type multi-temperature energy storage system and method based on LNG cold energy recovery 华南理工大学 2026-05-12 CN disclosed
CN-118955529-A Novel coupled crystallization method for preparing nafcillin sodium superior product 天津大学 2024-11-15 CN disclosed
EP-4190773-B1 THIOBENZOPYRAN COMPOUND AND APPLICATION THEREOF IN PREPARATION OF DRUG FOR TREATING RHEUMATOID ARTHRITIS HC SYNTHETIC PHARMACEUTICAL CO LTD (CN) 2024-11-13 EP disclosed
CN-118772842-A Pressure response plugging agent for oil and gas well and preparation method thereof 深圳市利特能源技术有限公司 2024-10-15 CN disclosed
US-12110282-B2 Thiobenzopyrans and their use in preparation of drugs for treatment of rheumatoid arthritis HC Synthetic Pharmaceutical Co., Ltd. (CN) 2024-10-08 US disclosed
CN-118382497-A Humidity-controlling material 夏普株式会社 2024-07-23 CN disclosed
EP-4345145-A1 DE-ICING, DUST BINDING AND/OR HEAT TRANSFER COMPOSITION Kemion OY (FI) 2024-04-03 EP disclosed
CN-113968838-B Thiobenzopyran compound and application thereof in treatment of rheumatoid arthritis 华创合成制药股份有限公司 2024-04-02 CN disclosed
CN-109574797-B Preparation method of chiral benzyl alcohol 上海彩迩文生化科技有限公司 2021-09-17 CN disclosed
CN-108137510-B Compound (I) 葛兰素史密斯克莱知识产权发展有限公司 2021-07-20 CN disclosed
US-10975081-B2 Substituted fused pyrazole compounds and their use as LRRK2 inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2021-04-13 US disclosed
EP-3325449-B1 HETEROCYCLIC COMPOUNDS, PARTICULARLY PYRIMIDINYLINDAZOLE COMPOUNDS FOR TREATING PARKINSON'S DISEASE GLAXOSMITHKLINE IP DEV LTD (GB) 2021-01-13 EP disclosed
US-20200079777-A1 COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-03-12 US disclosed
EP-3325449-A1 COMPOUNDS GlaxoSmithKline Intellectual Property Development Limited (GB) 2018-05-30 EP disclosed
WO-2017012576-A1 COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-01-26 WO disclosed
CN-1795964-A Heat Recovery System for Renewable Absorbent Materials YAGAOSI ADVANCED TECH CO LTD (HK) 2006-07-05 CN disclosed